Polymyalgia rheumatica with a low erythrocyte sedimentation rate: Comparison of 10 cases with 10 cases with high erythrocyte sedimentation rate

Journal of Clinical Rheumatology

Volumn 3, Issue 6, 1997, Pages 319-323

  Kanik, Keith S ^a   Bridgeford, Paul H ^a   Germain, Bernard F ^a   Espinosa, Luis R ^a   Lowenstein, Mitchell ^a   Valeriano Marcet, Joann ^a   Seleznick, Mitchel ^a   Vasey, Frank B ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Diagnosis; Erythrocyte sedimentation rate; Polymyalgia rheumatica

Indexed keywords

CORTICOSTEROID; PREDNISONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DRUG RESPONSE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HUMAN; LABORATORY DIAGNOSIS; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RHEUMATIC POLYMYALGIA;

EID: 0031406495     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124743-199712000-00003     Document Type: Article

References (39)

1. Healey LA. Polymyalgia rheumatica. In: McCarty DJ. editors. Arthritis and Allied Conditions. 9th ed. Philadelphia: Lea and Febiger; 1979. p. 681-4.
2. Jones JG, Hazleman BL. Prognosis and management of polymyalgia rheumatica. Ann Rheum Dis 1981;40:1-5.
3. Chuang TY, Hunder GG, Ilstrup DM, Kurland LT. Polymyalgia rheumatica: A 10-year epidemiologic and clinical study. Ann Intern Med 1982;97:672-60.
4. Ayoub WT, Franklin CM, Torrett D. Polymyalgia rheumatica. Duration of therapy and long term outcome. Am J Med 1985;79:309-15.
5. Kyle V, Cawston TE, Hazleman BL. Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up. Ann Rheum Dis 1989;48: 667-71.
6. Cohen MD, Ginsburg WW. Polymyalgia rheumatica. Rheum Dis Clin North Am 1990;16: 325-9.
7. Healey, LA, Wilske KR. Presentation of occult giant cell arteritis. Arthritis Rheum 1980;23:641-3.
8. Calamia KT, Hunder GG. Giant cell arteritis (temporal arteritis) presenting as fever of un-determined origin. Arthritis Rheum 1981;24:1414-8.
9. Dailey MP, Mcarty DJ. Polymyalgia begins at 40. Arch Intern Med 1979;139:743-4.
10. Espinoza LR, Espinoza CG. Temporal arteritis with normal ESR [letter]. Arch Intern Med 1980;140:281-2.
11. Hamilton CR, Shelley WM, Tumulty PA. Giant cell arteritis: including temporal arteritis and polymyalgia rheumatica. Medicine 1971;50:1-27.
12. Wise CM, Agudelo CA, Chmelewski WL, Mcknight KM. Temporal arteritis with low erythrocyte sedimentation rate: A review of five cases. Arthritis Rheum 1991;34:1571-4.
13. Neish PR, Sergent JS. Giant cell arteritis: A case with unusual neurologic manifestations and a normal sedimentation rate. Arch Intern Med 1991;151:378-80.
14. Helfgott SM, Kieval RI. Polymyalgia rheumatica in patients with a normal erythrocyte sedimentation rate. Arthritis Rheum 1996;39:304-7.
15. Gonzalez-Gay MA, Rodriguez-Valverder V, Blanco R, Fernandez-Suiero JL, Armona J, Figueroa M, and Martinez-Taboada VM. Polymyalgia rheumatica without significantly increased erythrocyte sedimentation rate. Arch Intern Med 1997;157:317-20.
16. Chou CT, Schumacher HR. Clinical and pathologic studies of synovitis in polymyalgia rheumatica. Arthritis Rheum 1984;27:1107-18.
17. Healey LA. Polymyalgia rheumatica and seronegative rheumatoid arthritis may be the same entity. J Rheumatol 1992;19:270-2.
18. Hunder GG, Goronzy J, Weyand C. Is seronegative rhumatoid arthritis in the elderly the same as polymyalgia rheumatica? Bull Rheum Dis 1994;43:1-3.
19. Mowat AG, Hazleman BL. Polymyalgia rheumatica: a clinical study with particular reference to arterial disease. J Rheumatol 1974;1:190-202.
20. Bird HA, Esselinck W, Dixon AJ, Mowat AG, Wood PHN. An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis 1979,38:434-9.
21. Bruk MI. Articular and vascular manifestations of polymyalgia rheumatica. Ann Rheum Dis 1967;26:103-13.
22. Ellis ME, Ralston S. The ESR in the diagnosis and management of the polymyalgia rheumatica/giant cell arteritis syndrome. Ann Rheum Dis 1983;42:168-70.
23. Zlonis M. The mystique of the erythrocyte sedimentation rate. Clin Lab Med 1993;13:787-800.
24. Lowe GD. Clinical Annotation: Should plasma viscosity replace the ESR? Br J Haematol 1994;86:6-11.
25. Wilhelm WF, Tillisch JH. Relation of sedimentation rate to age. Med Clin North Am 1951; 35:1209-11.
26. Bottiger LE, Svedberg CA. Normal erythrocyte sedimentation rate and age. Br Med J 1967;2:85-7.
27. Sox HC, Liang MH. The erythrocyte sedimentation rate. Arm Intern Med 1986;104:515-23.
28. Fauchald P, Rygvold O, Oystese B. Temporal arteritis and polymyalgia rheumatica. Ann Intern Med 1972;77:845-52.
29. Von-Knorring J. Treatment and prognosis in polymyalgia rheumatica and temporal arteritis. Acta Med Scand 1979;205:429-35.
30. Park JR, Jones JG, Hazlemann BL. Relationship of the sedimentation rate to acute phase protein in polymyalgia rheumatica and giant cell arteritis. Ann Rheum Dis 1981;40:493-5.
31. Sorensen S, Lorenzen I. Giant cell arteritis, Temporal arteritis and polymyalgia rheumatica. Acta Med Scand 1977;201:207-13.
32. Huston KA, Hunder GG, Lie JT, Kennedy RH, Elvebach LR. Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study. Ann Intern Med 1978;88:162-7.
33. Bevan AT, Dunnill MS, Harrison MJG. Clinical and biopsy findings in temporal arteritis. Ann Rheum Dis 1968;27:271-7.
34. Eshaghian J, Goeken JA. C-reactive protein in giant cell (cranial temporal) arteritis. Ophthalmology 1980;87:1160-6.
35. Brittain GP, McIlwaine GG, Bell JA, Gibson JM. Plasma viscosity or erythrocyte sedimentation rate in the diagnosis of giant cell arteritis. Br J Opthalmol 1991;75:656-9.
36. Dinant GJ, Habets GP, van der Tempel H, Knottnerus JA. Discriminating ability of plasma viscosity and erythrocyte sedimentation rate: A prospective study at the rheumatology out-patient department. Scan J Rheumatol 1992;21:186-9.
37. Dinant GJ, van Wersch JWJ, Goei The HS, et al. Plasma viscosity and erythrocyte sedimentation rate in inflammatory and noninflammatory rheumatic disorders. Clin Rheumatol 1992;11:66-71.
38. Kelly CA, McClelland J, Fail B, Walker D. Erythrocyte sedimentation rate, plasma and serum viscosity as measures of disease activity in rheumatoid arthritis. Br J Rheumatol 1987; 26;136-8.
39. Clark S, Tindall E, Bennett RM. A double-blind cross over trial of prednisone versus placebo in the treatment of fibrositis. J Rheumatol 1985;12:980-3.